AMSTERDAM — LUMICKS, a leading next generation life science tools company renowned for its innovative platforms for Dynamic Single-Molecule and Cell Avidity analysis, has installed its ground-breaking z-Movi® Cell Avidity Analyzer at INmune Bio (NASDAQ: INMB). INmune Bio is a clinical stage biotechnology company developing new therapies that modulate the innate immune system to treat cancer […]

Cambridge, UK – 21 July 2021 – Cresset, innovative provider of outstanding software for molecule discovery and design, is pleased to announce that OncoArendi Therapeutics SA (WSE: OAT), a biotechnology company which specializes in the discovery and development of new drugs, has licensed Flare™ for use in its internal development programs. Cresset software uses its proprietary descriptors of […]

London and San Francisco — Parkinson’s UK, the largest charitable funder of Parkinson’s research in Europe, has announced today that it is using Collaborative Drug Discovery’s CDD Vault informatics system to manage project data from the Parkinson’s Virtual Biotech its pioneering drug discovery arm. The Parkinson’s Virtual Biotech, which launched in 2017, is a program that is plugging the funding […]

Genedata Selector streamlines omics-based strain engineering and optimization workflows Basel, Switzerland — Genedata, a leading provider of advanced software solutions for R&D, today announced that Sanofi, a globally leading biopharmaceutical company, has extended its license for Genedata Selector® to facilitate the digitalization of their strain engineering and optimization workflows. Sanofi and Genedata have a longstanding […]

Celemics signs a supply agreement for BTSeq™ solution with Chinese Sanger sequencing service company – Celemics enters the Chinese DNA Sequencing market since its establishment – NGS-based BTSeq™ solution allows for highly accurate DNA sequencing with significantly reduced cost and time – The agreement scale is equivalent to 87% in celemics’ annual revenue Seoul, Korea: Celemics, […]

• Celemics enters the Chinese DNA Sequencing market since its establishment• NGS-based BTSeq™ solution allows for highly accurate DNA sequencing with significantly reduced cost and time • The agreement scale is equivalent to 87% in celemics’ annual reven Seoul, Korea – Celemics, Inc. (www.celemics.com), an NGS-based sequencing solution and bioinformatics company, Co-CEO Young-hoon Lee and […]

CAMBRIDGE, Mass. — Genetics Institute of America, a CLIA Certified/CAP Accredited DNA and RNA research and clinical laboratory, today announced that it has selected Ovation’s laboratory information management system (LIMS) to complement the growth of its advanced molecular testing business. Ovation’s suite of software and data products make it more efficient for molecular diagnostic labs […]

UPPSALA, Sweden — Olink Holding AB (publ) (Nasdaq: OLK) today announced that deCODE genetics, a global leader in analyzing and understanding the human genome, will have internal access to the Olink® Explore 3072 platform, comprised of approximately 3,000 high quality protein assays with a Next Generation Sequencing (NGS) read-out. Through an agreement between the two […]

Manufacturing partnership enables suspension-based manufacture of gene therapies and viral vector-based vaccines PORT WASHINGTON, N.Y. – Pall Corporation, a global leader in filtration, separation and purification, today announced a new contract worth more than $7M with full-service contract development and manufacturing organization (CDMO) Exothera S.A. The new contract with Pall will establish a suspension-based manufacturing platform […]

Genedata Bioprocess streamlines gene therapy development processes and drive decision-making across Encoded’s R&D organization Basel, Switzerland and South San Francisco, CA, USA — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Encoded Therapeutics, a biotech company focused on developing precision gene therapies for pediatric central nervous system (CNS) disorders, […]